Vilya
PrivateLast Round
Series A
Jun 4, 2024
Est. Valuation
$144M
Total Funding Raised
$142M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vilya operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Series A round in June 2024.
Vilya is a biotechnology company that develops a computational platform for creating a novel class of medicines that precisely target disease biology through the design of macrocycles.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vilya Comparables
Compare Vilya with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orbis Medicines | 86% | |
| Unnatural Products | 86% | |
| Curve Therapeutics | 82% |
For institutional investors. Book with your work email.
Vilya Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 4, 2024 | ||||
| Series A | Aug 29, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vilya Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Series A |
| WRF Capital | Series A |
| Lifeforce Capital | Series A |
| ARCH Venture Partners | Series A |
| NVentures | Series A |
| Madrona Venture Group | Series A |
| Menlo Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 84% MoM.
- Jun 4, 2024
$71M round led by NVentures and ARCH Venture Partners.
For institutional investors. Book with your work email.
Vilya Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vilya's valuation, stock price, and market status.
Is Vilya a public or private company?
Vilya is a private company.
What is the current stock price of Vilya?
Vilya is a private company, so its shares have no public market price. Caplight tracks Vilya's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vilya worth (valuation)?
Vilya's valuation is estimated at $144.0M based on funding round data.
Can I buy Vilya stock?
Vilya shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vilya's last funding round?
Vilya's most recent funding round was Series A on June 4, 2024.
Who are the main investors in Vilya?
Key investors in Vilya include ARCH Venture Partners, NVentures.
Will Vilya IPO soon?
No public IPO plans have been announced for Vilya.
How can I track Vilya secondary market activity?
Caplight tracks bids, offers, and trades in Vilya's shares on secondary markets.